产品名称
MS-SAFE蛋白酶和磷酸酶抑制剂,
description
for use with mammalian cell and tissue extract, lyophilized powder
Quality Level
form
powder
solubility
water: 0.1 g/mL, clear, colorless
storage temp.
2-8°C
General description
质谱(MS)兼容蛋白酶抑制剂鸡尾酒和磷酸酶抑制剂鸡尾酒,具有广泛的抑制特异性:
- 丝氨酸、半胱氨酸和天冬氨酸蛋白酶以及金属蛋白酶
- 酪氨酸、丝氨酸/苏氨酸、酸性和碱性磷酸酶
Application
在哺乳动物细胞裂解物和肝组织提取物中测试。设计用于质谱分析的样本。
MS-SAFE蛋白酶和磷酸酶抑制剂已用于测量核糖体蛋白S6激酶(S6K)活性。
Biochem/physiol Actions
蛋白酶抑制剂:丝氨酸、半胱氨酸和天冬氨酸蛋白酶以及金属蛋白酶。
磷酸酶抑制剂:酪氨酸、丝氨酸/苏氨酸、酸性和碱性磷酸酶
磷酸酶抑制剂:酪氨酸、丝氨酸/苏氨酸、酸性和碱性磷酸酶
Features and Benefits
用于质谱分析的综合蛋白酶和磷酸酶抑制剂混合物
与下游样品处理兼容,如 His 标记的蛋白纯化和磷酸肽富集
允许精确测量蛋白活性和鉴定磷酸化位点。
与下游样品处理兼容,如 His 标记的蛋白纯化和磷酸肽富集
允许精确测量蛋白活性和鉴定磷酸化位点。
Physical form
水溶性冻干粉末
Preparation Note
一小瓶使用水或提取/裂解缓冲液制备20 mL 1倍抑制剂鸡尾酒工作溶液。或者,可以通过加入2 mL水或提取/裂解缓冲液来制备10倍的浓缩液。然后,根据1倍工作溶液的需要,可以将该10倍溶液10倍稀释到提取/裂解缓冲液中。
Other Notes
蛋白酶抑制剂:
- 贝他定盐酸
- 亮抑酶肽
- 磷酰胺基二钠盐
- 胃蛋白酶抑制剂
- 弹性酶抑制剂
- 抑肽酶
- 甲磺酸萘福莫司他
- 抗蛋白酶
- 豆渣酸
- 氟化钠
- 原钒酸钠
- 草酸溴四胺酯
- β-乳糖
- DL-亮氨酸
Still not finding the right product?
Explore all of our products under MS-SAFE蛋白酶和磷酸酶抑制剂
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
相关内容
Select different protease inhibitor types based on your needs to prevent protein degradation during isolation and characterization and safeguard proteins in sample prep.
S K Sreedharan et al.
The Biochemical journal, 316 ( Pt 3), 777-786 (1996-06-15)
1-trans-Epoxysuccinyl-L-leucylamido(4-guanidino)butane (E-64) was shown to inhibit beta-trypsin by a reversible competitive mechanism; this contrasts with the widely held view that E-64 is a class-specific inhibitor of the cysteine proteinases and reports in the literature that it does not inhibit a
Junguo Ma et al.
Chemosphere, 194, 773-783 (2017-12-19)
A previous study showed that microcystin-LR (MC-LR) exerted cytotoxicity and induced apoptosis in HepG2 cells. In the present study, we investigated whether oxidative stress-mediated p53/p21
Aberrant REDD1-mTORC1 responses to insulin in skeletal muscle from Type 2 diabetics.
Williamson, D.L., et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 309, R855-R863 (2015)
